Trial Profile
Phase I study of OSI-7904L in combination with cisplatin in patients with advanced solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jan 2009
Price :
$35
*
At a glance
- Drugs OVI 237 (Primary) ; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- 31 Jan 2009 Actual end date (Dec 2004) added as reported by ClinicalTrials.gov.
- 01 Nov 2005 New trial record.